Polish (WIG) Pharma Industry Analysis
UpdatedJul 26, 2024
DataAggregated Company Financials
Companies5
- 7D7.6%
- 3M63.8%
- 1Y45.4%
- YTD51.5%
In the last week, the Pharma industry is up 21%, with Celon Pharma up 24%. In the last 12 months, the industry was up 47%. Earnings are forecast to grow by 109% annually.
Industry Valuation and Performance
Has the Polish Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 26 Jul 2024 | zł1.8b | zł310.8m | -zł61,217,640.00 | 11.4x | -30x | 5.9x |
| Sun, 23 Jun 2024 | zł1.1b | zł310.8m | -zł61,217,640.00 | 12x | -18.6x | 3.7x |
| Tue, 21 May 2024 | zł1.2b | zł315.1m | -zł43,109,632.00 | 13.3x | -28.1x | 3.9x |
| Thu, 18 Apr 2024 | zł1.1b | zł311.5m | -zł40,173,065.00 | 15.4x | -27.7x | 3.6x |
| Sat, 16 Mar 2024 | zł1.2b | zł311.5m | -zł40,173,065.00 | 17.8x | -29.8x | 3.8x |
| Mon, 12 Feb 2024 | zł1.2b | zł307.4m | -zł40,479,653.00 | 18x | -29.9x | 3.9x |
| Wed, 10 Jan 2024 | zł1.2b | zł308.7m | -zł39,880,934.00 | 11.7x | -30.1x | 3.9x |
| Fri, 08 Dec 2023 | zł1.2b | zł308.7m | -zł39,880,934.00 | 11.2x | -30.8x | 4x |
| Sun, 05 Nov 2023 | zł1.1b | zł302.0m | -zł44,782,495.00 | 11.2x | -25x | 3.7x |
| Tue, 03 Oct 2023 | zł1.1b | zł302.0m | -zł42,933,291.00 | 10.5x | -26.2x | 3.7x |
| Thu, 31 Aug 2023 | zł1.2b | zł287.0m | -zł53,882,152.00 | 10.7x | -22.8x | 4.3x |
| Sat, 29 Jul 2023 | zł1.2b | zł278.4m | -zł53,806,540.00 | 37.6x | -22.3x | 4.3x |
| Mon, 26 Jun 2023 | zł1.2b | zł278.4m | -zł53,806,540.00 | 36.7x | -22.1x | 4.3x |
| Wed, 24 May 2023 | zł1.1b | zł280.8m | -zł51,259,182.00 | 8.7x | -21.8x | 4x |
| Fri, 21 Apr 2023 | zł1.1b | zł273.2m | -zł44,427,333.00 | 8.7x | -24.3x | 4x |
| Sun, 19 Mar 2023 | zł1.1b | zł273.2m | -zł44,427,333.00 | 8.5x | -25.2x | 4.1x |
| Tue, 14 Feb 2023 | zł1.1b | zł270.3m | -zł44,201,704.00 | 7.7x | -25.8x | 4.2x |
| Thu, 12 Jan 2023 | zł1.1b | zł270.3m | -zł44,201,704.00 | 7.6x | -24.2x | 4x |
| Sat, 10 Dec 2022 | zł1.1b | zł270.3m | -zł44,201,704.00 | 7.6x | -24.8x | 4.1x |
| Mon, 07 Nov 2022 | zł978.0m | zł260.7m | -zł40,809,798.00 | 8.4x | -24x | 3.8x |
| Wed, 05 Oct 2022 | zł887.5m | zł260.8m | -zł40,391,998.00 | 9.4x | -22x | 3.4x |
| Fri, 02 Sep 2022 | zł981.4m | zł265.7m | -zł29,303,736.00 | 9.1x | -33.5x | 3.7x |
| Sun, 31 Jul 2022 | zł1.2b | zł264.2m | -zł29,985,890.00 | 11x | -38.4x | 4.4x |
| Tue, 28 Jun 2022 | zł1.0b | zł264.2m | -zł29,985,890.00 | 11.4x | -33.9x | 3.9x |
| Thu, 26 May 2022 | zł1.3b | zł269.1m | -zł24,188,890.00 | 10.3x | -54.8x | 4.9x |
| Sat, 23 Apr 2022 | zł1.7b | zł235.3m | -zł1,158,483.00 | 61.8x | -1488.3x | 7.3x |
| Mon, 21 Mar 2022 | zł1.8b | zł358.1m | zł72.0m | 12.7x | 25.5x | 5.1x |
| Wed, 16 Feb 2022 | zł2.0b | zł350.0m | zł71.4m | 18x | 27.7x | 5.6x |
| Fri, 14 Jan 2022 | zł2.3b | zł350.0m | zł71.4m | 15.1x | 31.8x | 6.5x |
| Sun, 12 Dec 2021 | zł2.2b | zł350.0m | zł71.4m | 14.5x | 30.7x | 6.3x |
| Tue, 09 Nov 2021 | zł2.5b | zł344.7m | zł81.6m | 11.4x | 30.6x | 7.2x |
| Thu, 07 Oct 2021 | zł2.4b | zł344.7m | zł82.7m | 11.4x | 28.9x | 6.9x |
| Sat, 04 Sep 2021 | zł2.6b | zł330.5m | zł86.5m | 11.6x | 30.1x | 7.9x |
| Mon, 02 Aug 2021 | zł2.5b | zł330.5m | zł86.5m | 10.4x | 28.7x | 7.5x |
Price to Earnings Ratio
28.7x
Current Industry PE
- Investors are optimistic on the Polish Pharmaceuticals industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 4.7x is lower than the industry's current PS ratio of 6.0x.
Past Earnings Growth
- Total earnings for the Pharmaceuticals industry have declined over the last three years, with the industry now making a loss overall.
- Revenues have also declined 2.0% per year, which is driving profits down.
Industry Trends
Which industries have driven the changes within the Polish Healthcare industry?
| PL Market | -2.84% | |
| Healthcare | 0.31% | |
| Pharma | 7.58% | |
| Pharma | 7.58% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| CLN Celon Pharma | zł30.50 | 13.6% +zł186.4m | 78.6% | PS7.4x | |
| MOC Molecure | zł14.90 | 0.7% +zł1.7m | -22.8% | PS129.8x | |
| CBD Cannabis Poland | zł0.54 | 5.1% +zł1.3m | 72.6% | PS378.1x | |
| LCN Labocanna | zł0.40 | 3.1% +zł254.4k | -7.8% | PS97.3x |